Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Revenue: 2009-2024

Historic Revenue for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to $92.1 million.

  • OptimizeRx's Revenue rose 2232.86% to $26.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.5 million, marking a year-over-year increase of 2418.46%. This contributed to the annual value of $92.1 million for FY2024, which is 2880.93% up from last year.
  • Latest data reveals that OptimizeRx reported Revenue of $92.1 million as of FY2024, which was up 2880.93% from $71.5 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Revenue registered a high of $92.1 million during FY2024, and its lowest value of $43.3 million during FY2020.
  • In the last 5 years, OptimizeRx's Revenue had a median value of $62.5 million in 2022 and averaged $66.1 million.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 7608.28% in 2020, then skyrocketed by 188.86% in 2022.
  • Over the past 5 years, OptimizeRx's Revenue (Annual) stood at $43.3 million in 2020, then soared by 41.51% to $61.3 million in 2021, then rose by 1.89% to $62.5 million in 2022, then grew by 14.53% to $71.5 million in 2023, then rose by 28.81% to $92.1 million in 2024.
  • Its last three reported values are $92.1 million in FY2024, $71.5 million for FY2023, and $62.5 million during FY2022.